Anton Wellstein Selected Research

Fibroblast Growth Factors (Fibroblast Growth Factor)

12/2020	Acute Kidney Injury Sensitizes the Brain Vasculature to Ang II (Angiotensin II) Constriction via FGFBP1 (Fibroblast Growth Factor Binding Protein 1).
1/2018	The Role of Fibroblast Growth Factor-Binding Protein 1 in Skin Carcinogenesis and Inflammation.
6/2014	Expression of a Secreted Fibroblast Growth Factor Binding Protein-1 (FGFBP1) in Angioproliferative Kaposi Sarcoma.
10/2008	Effect of FGF-binding protein 3 on vascular permeability.
8/2007	Effects on neurite outgrowth and cell survival of a secreted fibroblast growth factor binding protein upregulated during spinal cord injury.
12/2006	The angiogenic switch molecule, secreted FGF-binding protein, an indicator of early stages of pancreatic and colorectal adenocarcinoma.
12/2006	Tumor angiogenesis: initiation and targeting - therapeutic targeting of an FGF-binding protein, an angiogenic switch molecule, and indicator of early stages of gastrointestinal adenocarcinomas -.
1/2006	Expression of a fibroblast growth factor-binding protein during the development of adenocarcinoma of the pancreas and colon.
1/2006	Role of fibroblast growth factor-binding protein in the pathogenesis of HIV-associated hemolytic uremic syndrome.
6/2005	Vascular leakage in chick embryos after expression of a secreted binding protein for fibroblast growth factors.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Anton Wellstein Research Topics

Disease

49	Neoplasms (Cancer) 03/2022 - 03/2002
22	Breast Neoplasms (Breast Cancer) 01/2021 - 10/2002
10	Pancreatic Neoplasms (Pancreatic Cancer) 03/2022 - 03/2002
6	Disease Progression 12/2018 - 12/2012
6	Wounds and Injuries (Trauma) 01/2018 - 11/2011
6	Carcinogenesis 01/2018 - 09/2002
5	Adenocarcinoma 11/2019 - 09/2004
4	Noninfiltrating Intraductal Carcinoma (DCIS) 01/2021 - 05/2018
3	Inflammation (Inflammations) 01/2021 - 01/2018
3	Chronic Renal Insufficiency 11/2018 - 05/2015
3	Hypertension (High Blood Pressure) 01/2018 - 02/2006
3	Colorectal Neoplasms (Colorectal Cancer) 01/2014 - 01/2006
3	Glioblastoma (Glioblastoma Multiforme) 01/2012 - 04/2002
2	Cardiotoxicity 09/2021 - 01/2018
2	Pancreatitis 01/2021 - 09/2004
2	Papilloma (Papillomatosis) 01/2018 - 09/2004
2	Neoplasm Metastasis (Metastasis) 03/2014 - 03/2004
2	Colonic Neoplasms (Colon Cancer) 01/2014 - 12/2006
1	Esophageal Neoplasms (Esophageal Cancer) 09/2021
1	Triple Negative Breast Neoplasms 01/2021
1	Reperfusion Injury 12/2020
1	Acute Kidney Injury (Acute Renal Failure) 12/2020
1	Ductal Carcinoma 01/2020
1	Ovarian Neoplasms (Ovarian Cancer) 12/2019
1	Diabetes Mellitus 01/2019
1	Diabetic Angiopathies (Diabetic Angiopathy) 01/2019
1	Weight Gain 10/2018
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 10/2018
1	Hyperglycemia 10/2018

Drug/Important Bio-Agent (IBA)

15	Proteins (Proteins, Gene)FDA Link 01/2021 - 09/2002
14	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 06/2014 - 10/2002
13	Carrier Proteins (Binding Protein)IBA 12/2020 - 04/2003
13	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 12/2020 - 04/2003
11	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 09/2017 - 03/2002
8	Messenger RNA (mRNA)IBA 01/2021 - 04/2002
7	MicroRNAs (MicroRNA)IBA 03/2022 - 01/2011
7	DNA (Deoxyribonucleic Acid)IBA 09/2021 - 06/2015
6	Cell-Free Nucleic AcidsIBA 01/2021 - 06/2015
6	Hormones (Hormone)IBA 10/2017 - 05/2003
5	Phosphotransferases (Kinase)IBA 03/2022 - 04/2002
5	Angiotensin IIIBA 01/2021 - 02/2012
5	Biomarkers (Surrogate Marker)IBA 12/2019 - 01/2006
4	Pharmaceutical PreparationsIBA 12/2019 - 10/2002
4	pleiotrophin (HARP)IBA 09/2017 - 03/2002
4	Estrogens (Estrogen)FDA Link 01/2011 - 10/2002
4	Epidermal Growth Factor (EGF)IBA 07/2009 - 05/2003
4	Estrogen Receptor alphaIBA 11/2008 - 05/2003
4	Steroid Receptors (Steroid Receptor)IBA 11/2008 - 09/2006
3	Anaplastic Lymphoma KinaseIBA 03/2022 - 04/2002
3	CytokinesIBA 01/2021 - 02/2004
3	Protein Isoforms (Isoforms)IBA 01/2021 - 01/2004
3	Estrogen ReceptorsIBA 12/2019 - 11/2004
3	Reactive Oxygen Species (Oxygen Radicals)IBA 11/2018 - 07/2012
3	SteroidsIBA 04/2012 - 09/2006
3	Biological ProductsIBA 07/2009 - 12/2006
3	Insulin-Like Growth Factor I (IGF-1)IBA 11/2004 - 05/2003
2	Gemcitabine FDA Link 01/2021 - 01/2011
2	RNA (Ribonucleic Acid)IBA 01/2021 - 01/2016
2	Vasoconstrictor AgentsIBA 12/2020 - 01/2019
2	ProstaglandinsIBA 01/2019 - 05/2015
2	Glucose (Dextrose)FDA LinkGeneric 10/2018 - 12/2012
2	matrigelIBA 01/2018 - 11/2011
2	CarcinogensIBA 01/2018 - 09/2004
2	Tyrosine Kinase InhibitorsIBA 01/2018 - 10/2017
2	Heparin (Liquaemin)FDA LinkGeneric 09/2017 - 01/2016
2	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 12/2015 - 05/2015
2	NADPH Oxidases (NAD(P)H oxidase)IBA 07/2012 - 02/2006
2	tyrosine receptor (receptor, tyrosine)IBA 01/2012 - 04/2002
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2012 - 11/2008
2	Tyrosine (L-Tyrosine)FDA Link 11/2008 - 08/2007
2	Cyclin D1IBA 05/2008 - 03/2004
2	Staphylococcal Protein A (Protein A)IBA 12/2006 - 01/2006
2	Indicators and Reagents (Reagents)IBA 12/2006 - 12/2006
1	PD 173074IBA 03/2022
1	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 03/2022
1	NVP-TAE684IBA 03/2022
1	Paclitaxel (Taxol)FDA LinkGeneric 09/2021
1	Carboplatin (JM8)FDA LinkGeneric 09/2021
1	Versicans (Versican)IBA 01/2021
1	osteoblast cadherinIBA 01/2021
1	Glycoproteins (Glycoprotein)IBA 01/2021
1	Circulating Tumor DNAIBA 01/2021
1	Collagen Type I (Type I Collagen)IBA 01/2020
1	Transcription Factors (Transcription Factor)IBA 01/2020
1	Sepharose (Agarose)IBA 01/2020
1	Phenobarbital (Luminal)FDA Link 12/2019
1	palbociclibIBA 12/2019
1	Fenofibrate (CiL)FDA LinkGeneric 01/2019
1	SaltsIBA 11/2018
1	Nonesterified Fatty Acids (NEFA)IBA 10/2018
1	AdiponectinIBA 10/2018
1	efatutazoneIBA 05/2018
1	Tetradecanoylphorbol AcetateIBA 01/2018
1	Proteasome InhibitorsIBA 01/2018
1	Immune Checkpoint InhibitorsIBA 01/2018

Therapy/Procedure

10	Therapeutics 01/2022 - 03/2004
2	Radiotherapy 09/2021 - 01/2018
1	Neoadjuvant Therapy 09/2021
1	Injections 01/2021
1	Immunotherapy 01/2020